INTRODUCTION
Tuberculosis is a remarkably high risk communicable disease of human beings. The causative organism Mycobacterium tuberculosis is airborne and is often transmitted among people of lower income group suffering from malnutrition and immunological deficiencies. The World Health Organization (WHO, 2013) reported a total of 8.6 million new cases of tuberculosis and 1.3 million deaths due to this infection in 2012. In the treatment regime referred as Directly Observed Treatment Schedule (DOTS) isoniazid, rifampicin, ethambutol and pyrazinamide are administered for two months after presumptive diagnosis. Subsequently isoniazid and rifampicin are continued in the same patients for 4 to 7 months depending on the severity of infection. However, now there are more virulent forms designated as multi-drug resistant strains that are resistant to isoniazid and rifampicin. Apart from this many strains are found to be resistant to isoniazid, rifampicin, streptomycin, any fluoroquinilone plus any of the antitubercular injectables like amikacin/ kanamycin/ capreomycin. Such strains have evolved due to misuse or overuse of the scheduled drugs or failure in continuation of the correct therapy. These strains may also arise if the treatment schedule is allowed to continue for more than 12 months. Simultaneous application of so many drugs creates sufficient pressure for the causative organism to select multi-drug resistant mutants. Such a situation could not have occurred by a simple mode of action since different drugs have different sites of action. The modes of action of anti-tubercular drugs are very varied, although structurally similar drugs usually have the same mutated target. The occurrence and prevalence of tuberculosis by drug resistant organisms initiated systematic search for antimycobacterial agents from various existing pharmacological agents by several groups of researchers in different parts of the world. Such studies revealed that antipsychotic and antihistaminic phenothiazines possess powerful antitubercular action. Most potent among these were thioridazine, methdilazine, trifluoperazine, chlorpromazine and promethazine (Molnar et Occurrence of cross-resistances among aminoglycosides in Mycobacterium tuberculosis was reported as far back as 1959 by several workers (Torii et al., 1959; Tsukamura, 1959) . Koseki & Okamoto (1963) presented evidences for a significant change in resistance to viomycin caused by development of resistance to capreomycin in Mycobacterium tuberculosis. Tsukamura (1969) while trying to produce drug resistant mutants in the laboratory found that highly kanamycin resistant M.tuberculosis strains were resistant to capreomycin and strains moderately resistant to kanamycin were susceptible to capreomycin. He further observed that experimentally produced capreomycin resistant strains failed to develop resistance to kanamycin. Such a one way cross-resistance relationship was observed among many other aminoglycosides (Tsukamura,1974). Tsukamura and Mizuno (1975) while trying to determine cross-resistance relationships among aminoglycosides in M.tuberculosis reported that resistances to several antibiotics could be produced by a single mutation to any one of the agents. In 2005 Maus et al attempted to analyze cross-resistance to capreomycin, kanamycin, amikacin and viomycin in M.tuberculosis at molecular level. According to these authors mutation of the thyA gene confer capreomycin and viomycin resistance in M.tuberculosis. It is known that in mutations in the 16S rRNA gene (rrs) have been associated with resistance to all these four drugs (Suzuki et al., 1998) . Maus et al (2005) reported three rrs mutations in their M.tuberculosis test strains each of which was associated with a particular crossresistance pattern. They opined that when M.tuberculosis strains are exposed to one or two drugs phenotypic and genotypic differences can be seen in the development of antibiotic cross-resistance. In the present study we have tried to determine the ability of antitubercular phenothiazine compounds methdilazine and promethazine to produce mutants resistant to themselves and also to detect if such mutants develop crossresistances to known antitubercular agents.
Several chemotherapeutic agents applied to human beings for past few decades for different ailments, have been found to possess potent antitubercular activity. Two such agents, methdilazine (Md) and promethazine (Pz) were used to select mycobacterial mutants resistant to themselves at different levels and tested to determine if such mutants simultaneously developed cross-resistance to known antitubercular drugs. Mutants were produced by application of a heavy inoculum on Lowenstein-Jensen medium containing Md (or Pz) at concentrations higher than their respective minimum inhibitory concentrations (MICs). These were then tested to find out if such mutants have changed their resistogramme pattern with respect to the test antitubercular agents. Certain first-step Md-mutants became simultaneously resistant to ethambutol and pyrazinamide; while the step-2 Md-mutants revealed further increase in resistance to these agents along with resistance to isoniazid, rifampicin and streptomycin as well. In the study with Pz it was noted that many mutants showed distinctly higher levels of resistance to all the test drugs, particularly to isoniazid, pyrazinamide and streptomycin. The levels of MIC were distinctly high in many mutants. These observations on cross-resistances seem to be best explained on the basis of a reduction in cell-membrane permeability acting in a non-specific manner. The role of such a cross-resistance may possibly be accounting for an overall increase in the MICs of many drugs against several groups of microorganisms including Mycobacterium tuberculosis and other species of Mycobacterium during the last five decades. All the organisms were received as live culture slants in Lowenstein-Jensen Medium (LJM) from both the institutions and maintained in the same medium throughout the study.
MATERIAL AND METHODS

Strains
Media
All the biological components were obtained from Oxoid (UK). Kirchner's Liquid Medium (KLM) and LJM were prepared as per established protocol (Barrow and Feltham, 2003 
Overlay medium
This was prepared with 7H10 agar base, distilled water and glycerol, distributed in 2mL amounts and sterilized by autoclaving.
Inoculation
The known standard strains M.tuberculosis H37Rv 102 and H37Ra 16 along with all the other mycobacteria were grown in KLM, vortexed, diluted and standardized. Mcfarland standard 0.5 (in turbidity standard; the turbidity standard was prepared by adding 0.5 ml of a barium chloride solution to 99.5 ml of 1% H2SO4) was routinely taken for inoculation of all the strains and their mutants.
Media containing antitubercular drugs and other selecting agents
The agents were obtained in pure dry powder form from their manufacturers in India and stored at 4°C. To 2ml of overlay medium was added, any of the following agents: isoniazid acid hydrazide (INH), rifampicin (Rf), ethambutol (Eb), pyrazinamide (Pz), streptomycin (Sm), methdilazine (Md) and promethazine (Pz). The final concentration (µg/ml) of each of the agents were: 1,2,5,10,25,50,100, 200,400, 800, 1000 and 2000; these were added to the overlay medium before being allowed to flow over the freshly prepared LJM slants. All such bottles were inoculated for appearance of growth.
Determination of Minimum Inhibitory Concentration (MIC)
The MIC of the agents for different strains of Mycobacterium and their mutants were determined by inoculating the media as described above and incubating at 37°C. Appearance of growth was checked every day up to 3 weeks. Adequate strain and media controls were run throughout the tests.
Production and isolation of Md and Pz mutants
This was done by application of a heavy inoculum on LJM containing Md, the amount being higher than the MIC of the organism with respect to the agent. As the mutants developed they were designed as Step 1 mutants and were inoculated on LJM containing still higher amount of Md. The colonies developing on such a medium were designated as Step 2 mutant. In this way higher steps of mutants were selected with both Md and Pz. The relationship of the mutants with respect to the original wild types was determined with the help of various known and standardized morphological and biochemical parameters as described earlier.
RESULTS AND DISCUSSION
Sensitivity of bacteria
The minimum inhibitory concentration (MIC) of INH, Rf, Eb, Py,Sm,Md nd Pz with respect to 20 strains of Mycobacterium is presented on Table 1 . These strains were selected on the basis of previous studies that had revealed that most of these were sensitive to the test drugs including the phenothiazines at low concentrations. The MIC of INH, Py and Sm in the recent clinical isolates M.tuberculosis Bajaj 1, J15 and N23 was rather high. In M.tuberculosis Bajaj 1, the MIC of INH and Sm was 25µg/ml. The strain N23 was even more resistant, the MIC of Py and Sm was as high as 50µg/ml. With respect to the phenothiazines, the MIC values ranged between 10 and 25µg/ml in most of the test strains; however, in case of Bajaj 1, J15 and N23 the MIC of Md and Pz was 50µg/ml. The step-wise mutants produced by mycobacteria against Pz showed nearly similar pattern of increase in resistances against the antitubercular drugs.
However, in case of M.intracellulare 1406 there was a loss in the MIC value of Eb (Table 3) . 
DICUSSION
Prevalence of cross-resistances between aminoglycosides in drug-resistant mutants of M.tuberculosis has been studied extensively. Resistance to kanamycin in viomycin-resistant strains and resistance to streptomycin in kanamycinresistant strains were two to four times greater than the resistant levels of the parent strains of M.tuberculosis (Torii et al., 1959; Steenken et al., 1959) . Tsukamura (1974) isolated two types of tuberactinomycin N resistant mutants of M.tuberculosis, the first one was resistant to low levels of tuberactinomycin N, viomycin and capreomycin, while the other was resistant at high levels to all these three antibiotics plus kanamycin and lividomycin. With the help of an intensive study Tsukamura and Mizuno in 1975 proved that aminoglycoside antibiotics could be classified into three major types: streptomycin resistance, combined viomycin-tuberactinomycin N-capreomycin resistance, and the third type included resistance to kanamycin, lividomycin and paramomycin. No crossresistance between streptomycin and any other amionoglycoside antibiotic was Mutations conferring drug resistances were detected by GenoType MTBDR plus and DNA sequences. Isoniazid and ethionamide cross resistance was detected in 95.12 % of isoniazid resistant isolates harbouring a mutation in inhAP or inhA open reading frame, but rifabutin cross-resistance was observed in 90% of clinical isolates originally shown to be resistant to rifampicin. This study highlighted that the same mutation causing resistance to the first line antitubercular drugs can be responsible for resistance to their respective structural analogs. Such findings are expected to help clinicians to decide on the treatment regime. In this study it has been observed that Md mutants of M.phlei L1 developed cross-resistance to INH, Rf, Eb and Py in stepwise manner but not to Sm; with respect to M.flavescens 1541 the Md mutants developed cross-resistances to INH, Eb, Py, Sm and not To Rf. Wild type clinical isolates M.tuberculosis Bajaj 1, J15 and N23 had much higher level of MIC of all the test drugs, except Rf. Surprisingly, step-up mutants of all these 3 strains failed to develop resistance to Rf as well. On the contrary, resistance level of Eb decreased in step-two mutants of M.tuberculosis N23. Similar decrease in MIC of Sm was noted in M.avium 724 ( Table 2 ). The Pz-resistant step-three mutants of M.marinum 50 and M.intracellulare 1406 were resistant to Pz at very high levels and increase in MIC values of Eb in these mutants was also significantly high. The resistances of wild-type and mutant mycobacteria differed in most instances by sufficiently large margins (within the limits of confidence of the test system), and therefore appeared to be truly reflective of the actual resistance of such mycobacteria. It is unlikely that the low levels of resistances exhibited by some of the mutants were due to their reduced growth rate, incubation period was kept for sufficiently long period even for slow-growers and these resistances did not seem to depend on drug-modifying enzymes; these, therefore, should not affect their MIC determination. Indeed MICs of several test drugs were found to be elevated simultaneously. Thus these observations on cross-resistance seem to be more easily explainable on the basis of a non-specific reduction in cell membrane permeability of the various Md and Pz mutants in varying degrees and selectivity with respects to different test drugs. A literature survey on the MICs of different antibiotics shows that there had been a significant rise in the highest values that characterize drug resistant strains as well as the lowest values of MICs of drugs/antibiotics (characterizing sensitive strains) with respect to almost all groups of pathogenic bacteria during the last five decades since the beginning of antibiotic era (Garrod and O' Grady, 1971; Ray et al., 1980) . Development of such resistances has been ascribed to "intrinsic resistance" which is an evolutionary ancient phenotype and can be defined as resistance of any bacterial species to a particular drug/antibiotic that has not been acquired as a result of exposure to such agents (Fajardo et al., 2008) . Intrinsic resistance is the result of reduced permeability of bacterial envelope and the activity of efflux pumps (Nikaido and Zgurskaya, 1999) . This suggests that the main physiological role of the components of intrinsic resistance involves the prevention of toxic components by restricting the permeability of the cell or the active export of toxic compounds. However, intrinsic resistance of M.tuberculosis has been traditionally attributed to the unusual structure of its mycolic acid containing cell wall that contributes to the low permeability for antitubercular antibiotics and chemotherapeutics (Jarker and Nikaido, 1994) . The role of efflux mechanisms has been recognized as an important factor in the natural resistances of mycobacteria against tetracyclines, aminoglycosides and fluoroquinolones ( . It may be plausible to presume that many or all of these drugs could have selected mutants resistant to themselves and non-specifically to other antitubercular drugs all at low levels, at the therapeutic dosages at which they are used, thus contributing towards a gradual rise of the baseline of MIC of antitubercular agents. The present study provides experimental evidences for one of such possibilities.
CONCLUSION
The accelerated speed with which tuberculosis has spread in all communities throughout the world and the higher frequency of infection by multidrug and extensively drug resistant M. tuberculosis have resulted in an alarming situation. In this study it was observed that many strains of M.tuberculosis could be inhibited by both the phenothiazines methdilazine and promethazine.Thus these findings open up a new arena of treatment for multidrug and extensively drug resistant mycobacteria. It may be pointed out here that a structurally similar phenothiazine, thioridazine, has been repeatedly proved to be a potent antitubercular drug. Both the two compounds methdilazine and promethazine are routinely used as antihistaminic drugs while thioridazine is an effective antipsychotic drug. It needs to be pointed out here that since both methdilazine and promethazine are given to patients as antihistaminics and not as neuroleptics development of track resistance is not possible on the basis of prescription. Since the structurally similar neuroleptic drug thioridazine has repeatedly shown to be active against M.tuberculosis all such phenothiazines may be grouped together to define the results as a " class mechanism". When the antihistaminic compounds methdilazine and promethazine were allowed to produce mutants resistant to either of them at higher levels, the organisms showed elevated levels of MIC of tested antitubercular drugs. Such a phenomenon may be attributed as intrinsic resistance, which is the result of reduced permeability of bacterial envelope alongwith action of efflux pumps,which, in turn, result in prevention of toxic components into the cell. Therefore, it may be plausible that prolonged and indiscriminate use of such phenothiazines having antitubercular action, often unknowingly, may have allowed development of mutants resistant to themselves and simultaneously cross-resistances to many routinely used antitubercular drugs.
